Bastide Le Confort Médical SA (0IP1.L)
EUR 24.1
(-4.55%)
EUR 24.1
(-4.55%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 1.91 Million EUR | -99.35% |
| 2023 | 294.37 Million EUR | 6.82% |
| 2022 | 275.58 Million EUR | 9.71% |
| 2021 | 251.18 Million EUR | 12.41% |
| 2020 | 223.46 Million EUR | 10.6% |
| 2019 | 202.05 Million EUR | 19.8% |
| 2018 | 168.66 Million EUR | 28.26% |
| 2017 | 131.49 Million EUR | 18.67% |
| 2016 | 110.8 Million EUR | 12.97% |
| 2015 | 98.08 Million EUR | 11.57% |
| 2014 | 87.91 Million EUR | 14.92% |
| 2013 | 76.49 Million EUR | 8.67% |
| 2012 | 70.39 Million EUR | 15.75% |
| 2011 | 60.81 Million EUR | 10.93% |
| 2010 | 54.82 Million EUR | 0.95% |
| 2009 | 54.3 Million EUR | 8.97% |
| 2008 | 49.83 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 157.34 Million EUR | 0.0% |
| 2024 Q4 | 1.92 Million EUR | 0.0% |
| 2023 Q2 | 145.77 Million EUR | 0.0% |
| 2023 FY | 294.37 Million EUR | 6.82% |
| 2023 Q4 | 148.59 Million EUR | 0.0% |
| 2022 FY | 275.58 Million EUR | 9.71% |
| 2022 Q4 | 145.53 Million EUR | 0.0% |
| 2022 Q2 | 130.04 Million EUR | 0.0% |
| 2021 Q4 | 127.21 Million EUR | 0.0% |
| 2021 Q2 | 123.97 Million EUR | 0.0% |
| 2021 FY | 251.18 Million EUR | 12.41% |
| 2020 Q2 | 102.97 Million EUR | 0.0% |
| 2020 Q4 | 120.48 Million EUR | 0.0% |
| 2020 FY | 223.46 Million EUR | 10.6% |
| 2019 Q4 | 103.29 Million EUR | 0.0% |
| 2019 FY | 202.05 Million EUR | 19.8% |
| 2019 Q2 | 98.76 Million EUR | 0.0% |
| 2018 FY | 168.66 Million EUR | 28.26% |
| 2018 Q4 | 89.23 Million EUR | 0.0% |
| 2018 Q2 | 79.42 Million EUR | 0.0% |
| 2017 Q2 | 63.06 Million EUR | 0.0% |
| 2017 FY | 131.49 Million EUR | 18.67% |
| 2017 Q4 | 68.43 Million EUR | 0.0% |
| 2016 FY | 110.8 Million EUR | 12.97% |
| 2016 Q2 | 53.42 Million EUR | 0.0% |
| 2016 Q4 | 57.37 Million EUR | 0.0% |
| 2015 FY | 98.08 Million EUR | 11.57% |
| 2015 Q2 | 48.07 Million EUR | 0.0% |
| 2015 Q4 | 50 Million EUR | 0.0% |
| 2014 FY | 87.91 Million EUR | 14.92% |
| 2014 Q4 | 44 Million EUR | 0.0% |
| 2014 Q2 | 43.9 Million EUR | 0.0% |
| 2013 Q4 | 38.74 Million EUR | 0.0% |
| 2013 Q2 | 37.74 Million EUR | 0.0% |
| 2013 FY | 76.49 Million EUR | 8.67% |
| 2012 Q4 | 308.5 Thousand EUR | 0.0% |
| 2012 Q3 | 308.5 Thousand EUR | 0.0% |
| 2012 FY | 70.39 Million EUR | 15.75% |
| 2012 Q2 | 308.5 Thousand EUR | 5.56% |
| 2012 Q1 | 292.25 Thousand EUR | 0.0% |
| 2011 Q1 | 5.47 Million EUR | 0.0% |
| 2011 Q2 | 292.25 Thousand EUR | -94.66% |
| 2011 Q3 | 292.25 Thousand EUR | 0.0% |
| 2011 Q4 | 292.25 Thousand EUR | 0.0% |
| 2011 FY | 60.81 Million EUR | 10.93% |
| 2010 Q3 | 5.47 Million EUR | 0.0% |
| 2010 Q4 | 5.47 Million EUR | 0.0% |
| 2010 Q2 | 5.47 Million EUR | 778.85% |
| 2010 FY | 54.82 Million EUR | 0.95% |
| 2010 Q1 | 623 Thousand EUR | 0.0% |
| 2009 Q4 | 623 Thousand EUR | 0.0% |
| 2009 Q3 | 623 Thousand EUR | 0.0% |
| 2009 Q2 | 623 Thousand EUR | 8.92% |
| 2009 Q1 | 572 Thousand EUR | 0.0% |
| 2009 FY | 54.3 Million EUR | 8.97% |
| 2008 FY | 49.83 Million EUR | 0.0% |
| 2008 Q4 | 572 Thousand EUR | 0.0% |
| 2008 Q3 | 572 Thousand EUR | 0.0% |
| 2008 Q2 | 572 Thousand EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cegedim SA | 235.64 Million EUR | 99.188% |
| Guerbet SA | 550.79 Million EUR | 99.653% |
| Nexus AG | 44.98 Million EUR | 95.745% |
| Revenio Group Oyj | 18.8 Million EUR | 89.819% |
| Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 99.851% |
| Sartorius Aktiengesellschaft | 1.02 Billion EUR | 99.813% |
| LNA Santé SA | 178.1 Million EUR | 98.925% |
| Siemens Healthineers AG | 5.59 Billion EUR | 99.966% |
| Medios AG | 23.03 Million EUR | 91.691% |
| Equasens Société anonyme | 14.67 Million EUR | 86.953% |
| Stratec SE | 41.95 Million EUR | 95.438% |